Pierandrea Muglia
Förmögenhet: 387 817 $ per 2026-07-31
Förmögenhet: 387 817 $ per 2026-07-31
Pierandrea Muglia is the founder of GRIN Therapeutics, Inc. Currently, Dr. Muglia is Chief Executive Officer at Ichnos SRL and Chief Medical Officer at Saniona AB starting in 2023.
Formerly, Dr. Muglia was Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A, Chief Marketing Officer at Handl Therapeutics BV, and Vice President at UCB Pharma SA (Belgium) from 2012 to 2019.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SANIONA AB 0,19 % | 2024-12-31 | 259 999 ( 0,19 % ) | 387 817 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| SANA AB | Teknisk/Vetenskaplig/F&U Direktör | 2025-03-10 |
| Företag | Position | Slut |
|---|---|---|
GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of precision therapeutics for pediatric neurodevelopmental disorders | Grundare | 2022-09-01 |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Företagsledare/Principal | 2019-10-01 |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Försäljning & Marknadsföring | - |
| NTG NORDIC TRANSPORT GROUP A/S | Direktör/Styrelseledamot | 2010-05-28 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
NTG Nordic Transport Group A/S
NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Health Technology |
GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of precision therapeutics for pediatric neurodevelopmental disorders | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån